Pharmacyclics Inc - Strategic SWOT Analysis Review

  • ID: 4377305
  • SWOT Analysis
  • 22 pages
  • GlobalData
  • Pharmacyclics llc
1 of 5

FEATURED COMPANIES

  • Ambrilia Biopharma Inc
  • Aphios Corp
  • CTI BioPharma Corp
  • MORE
Pharmacyclics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
Highlights

Pharmacyclics Inc (Pharmacyclics), a wholly-owned subsidiary of AbbVie, discovers, develops and commercializes novel therapies for the treatment of cancer and immunemediated diseases. The company’s drugs and drug candidates are synthetic small-molecules that target major biochemical pathways that are associated with human diseases that have high unmet clinical need. It markets Imbruvica and has two drug candidates in clinical development and preclinical molecules in lead optimization. Imbruvica (ibrutinib), Pharmacyclics's first commercial product has been approved by the US FDA for the treatment of patients with mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL) and Waldenstrom’s macroglobulinemia (WM). Pharmacyclics is headquartered in Sunnyvale, California, the US.

Reasons to buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with this detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Ambrilia Biopharma Inc
  • Aphios Corp
  • CTI BioPharma Corp
  • MORE
Section 1 - About the Company
  • Pharmacyclics Inc - Key Facts
  • Pharmacyclics Inc - Key Employees
  • Pharmacyclics Inc - Major Products and Services
  • Pharmacyclics Inc - History
  • Pharmacyclics Inc - Company Statement
  • Pharmacyclics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Pharmacyclics Inc - Business Description
  • Pharmacyclics Inc - Corporate Strategy
  • Pharmacyclics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Pharmacyclics Inc - Strengths
  • Pharmacyclics Inc - Weaknesses
  • Pharmacyclics Inc - Opportunities
  • Pharmacyclics Inc - Threats
  • Pharmacyclics Inc - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Pharmacyclics Inc, Recent Deals Summary
Section 4 - Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Pharmacyclics Inc, Key Facts
  • Pharmacyclics Inc, Key Employees
  • Pharmacyclics Inc, Major Products and Services
  • Pharmacyclics Inc, History
  • Pharmacyclics Inc, Other Locations
  • Pharmacyclics Inc, Key Competitors
  • Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Pharmacyclics Inc, Recent Deals Summary
List of Figures
  • Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Novartis Vaccines and Diagnostics Inc
  • CTI BioPharma Corp
  • Aphios Corp
  • Ambrilia Biopharma Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll